⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11255228 | 0.81 | — | — | |
| SCHEMBL23234265 | 0.55 | MEN1 (0.41) | — | |
| SCHEMBL10993767 | 0.53 | — | — | |
| SCHEMBL30883381 | 0.52 | — | — | |
| SCHEMBL29663 | 0.52 | — | — | |
| SCHEMBL93744 | 0.52 | — | — | |
| SCHEMBL11602107 | 0.52 | — | — | |
| SCHEMBL3930260 | 0.52 | — | — | |
| SCHEMBL29664 | 0.52 | — | — | |
| SCHEMBL6244671 | 0.52 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119072304-A | Neuroactive steroids for the treatment of CNS related disorders | 萨奇治疗股份有限公司 | 2024-12-03 | — | — | CN | claimed |
| CN-113573723-B | Synthetic neuromodulatory peptides | 拉托科公司 | 2024-12-03 | — | — | CN | claimed |
| CN-119015253-A | Water-medicine complex and preparation method thereof | 天津医科大学第二医院 | 2024-11-26 | — | — | CN | claimed |
| CN-118370739-A | Chlorine nitrogen gentle and controlled release preparation and preparation method thereof | 湖南中南制药有限责任公司 | 2024-07-23 | — | — | CN | claimed |
| CN-110891562-B | Lithium salts of N-substituted glycine compounds and uses thereof | 心悦生医股份有限公司 | 2024-07-16 | — | — | CN | claimed |
| CN-117836284-A | Methods of treating nerve agent-induced seizures | 普罗尼拉斯公司 | 2024-04-05 | — | — | CN | claimed |
| CN-116087170-A | Method for rapidly detecting four stimulants based on surface-enhanced Raman spectrum | 厦门大学 | 2023-05-09 | — | — | CN | claimed |
| CN-110730781-B | Tetrahydropyridopyrazine modulators of GPR6 | 武田药品工业株式会社 | 2023-05-05 | — | — | CN | claimed |
| EP-1931320-B1 | MICROPARTICLES WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE PRINCIPLE AND ORAL DOSAGE FORM COMPRISING THE SAME | FLAMEL IRELAND LTD (IE) | 2022-06-15 | — | — | EP | claimed |
| US-20090220611-A1 | Microparticles With Modified Release of At Least One Active Principle and Oral Pharmaceutical Form Comprising Same | FLAMEL TECHNOLOGIES, S.A. (FR) | 2009-09-03 | — | — | US | claimed |
| EP-1931320-A2 | MICROPARTICLES WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE PRINCIPLE AND ORAL GALENIC FORM COMPRISING SAME | Flamel Technologies (FR) | 2008-06-18 | — | — | EP | claimed |
| WO-2007036671-A2 | MICROPARTICLES WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE PRINCIPLE AND ORAL GALENIC FORM COMPRISING SAME | FLAMEL TECHNOLOGIES (FR) | 2007-04-05 | — | — | WO | claimed |
| EP-1273301-B1 | Pharmaceutical preparations based on active ingredients susceptible to illicit administration | ALTERGON SA (CH) | 2006-09-06 | — | — | EP | claimed |
| CN-122042350-A | Rapid sample pretreatment device and method for paper purification and application of rapid sample pretreatment device and method in mass spectrometry | 南京警察学院 | 2026-05-15 | — | — | CN | disclosed |
| CN-115667235-B | Compositions and methods for treating disorders ameliorated by muscarinic receptor activation | 卡鲁娜治疗学有限公司 | 2025-06-17 | — | — | CN | disclosed |
| CN-120154690-A | Traditional Chinese medicine essential oil composition for preventing and/or treating insomnia and preparation method and application thereof | 上海安好合医药开发有限公司 | 2025-06-17 | — | — | CN | disclosed |
| US-20040180088-A1 | Gastric retention controlled drug delivery system | SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) | 2004-09-16 | — | — | US | disclosed |
| CN-1520286-A | Gastric retention controlled drug delivery system | ̫��ҽҩ��ҵ����˾ | 2004-08-11 | — | — | CN | disclosed |
| EP-1411901-A1 | GASTRIC RETENTION CONTROLLED DRUG DELIVERY SYSTEM | Sun Pharmaceuticals Industries Ltd. (IN) | 2004-04-28 | — | — | EP | disclosed |
| WO-2003011255-A1 | GASTRIC RETENTION CONTROLLED DRUG DELIVERY SYSTEM | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2003-02-13 | — | — | WO | disclosed |